Predicting which medication classes interfere with allergy skin testing

Allergy and Asthma Proceedings

Volumn 31, Issue 6, 2010, Pages 477-482

  Shah, Kunal M ^a   Rank, Matthew A ^a   Davé, Shoban A ^b   Oslie, Corrine L ^a   Butterfield, Joseph H ^a  

^a MAYO CLINIC   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; CETIRIZINE; CIMETIDINE; CITALOPRAM; CLONAZEPAM; DESLORATADINE; DIAZEPAM; DULOXETINE; ESCITALOPRAM; ESOMEPRAZOLE; ESZOPICLONE; FEXOFENADINE; FLUOXETINE; HISTAMINE; LANSOPRAZOLE; LORATADINE; MIDAZOLAM; MIRTAZAPINE; NORTRIPTYLINE; OMEPRAZOLE; PAROXETINE; QUETIAPINE; RANITIDINE; SERTRALINE; TRAZODONE; UNINDEXED DRUG; VENLAFAXINE; ZOLPIDEM;

ALLERGY TEST; ARTICLE; CONTROLLED STUDY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREDICTION; PRICK TEST; RETROSPECTIVE STUDY; SKIN TEST; TREATMENT WITHDRAWAL;

CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; DIAGNOSTIC ERRORS; DRUG INTERACTIONS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HISTAMINE H2 ANTAGONISTS; HUMANS; HYPERSENSITIVITY; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SKIN TESTS; WITHHOLDING TREATMENT;

EID: 78650447868     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3382     Document Type: Article

References (13)

1. Nelson HS. Variables in allergy skin testing. Allergy Proc 15: 265-268, 1994.
2. Demoly P, Bousquet J, and Romano A (Ed). In vivo Methods for Study of Allergy: Skin Tests, Techniques and Interpretation, Chapter 71, 7th ed. New York: Mosby, 1271-1272, 2008.
3. Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: An updated practice parameter. Ann Allergy Asthma Immunol 100:S1-S148, 2008.
4. Miller J, and Nelson HS. Suppression of immediate skin tests by ranitidine. J Allergy Clin Immunol 84:895-899, 1989.
5. Rao KS, Menon PK, Hilman BC, et al. Duration of the suppressive effect of tricyclic antidepressants on histamine-induced wheal-and-flare reactions in human skin. J Allergy Clin Immunol 82:752-757, 1988.
6. Stahl SM. Selective histamine H1 antagonism: Novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr 13:1027-1038, 2008.
7. Hellbom E. Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment. Med Hypotheses 66:689-690, 2006.
8. Duenas-Laita A, Ruiz-Munoz P, Armentia A, et al. Successful treatment of chronic drug-resistant urticaria with alprazolam. J Allergy Clin Immunol 123:504-505, 2009.
9. Rao KS, Menon PK, Hilman BC, et al. Duration of the suppressive effect of tricyclic antidepressants on histamine-induced wheal-and-flare reactions in human skin. J Allergy Clin Immunol 82:752-757, 1988.
10. Meyrick Thomas RH, Browne PD, and Kriby JD. The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal and flare reactions in human skin. J Allergy Clin Immunol 76:864-869, 1985.
11. Kupczyk M, Kupryś I, Bocheńska-Marciniak M, et al. Ranitidine (150 mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests. Allergy Asthma Proc 28:711-715, 2007.
12. Weller K, and Maurer M. Desloratadine inhibits human skin mast cell activation and histamine release. J Invest Dermatol 129:2723-2726, 2009.
13. Stahl SM. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59(suppl 40):5-14, 1998.